Gauchers Disease
Conditions
Interventions
None listed
Sponsors
Mebix, Inc Research Operation Depertment
Definitive Diagnosis Organization by measuring GCB activity Mass Screening Team, Department of Pediatrics, Graduate School of Medical Sciences, Kumamoto University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients who were diagnosed as suspicion of Gauchers disease 2.Patients whom the written informed consent was obtained by him/herself or by proxy at the time of study enrollment 3.Patients whose number of platelets are less than 120000/micro L
Exclusion criteria
Exclusion criteria: 1.Patients who were definitively diagnosed as idiopathic thrombocytopenic purpura (ITP) 2.Patients who were definitively diagnosed as aplastic anemia 3. Patients whom the principal investigator judged not to be eligible as a target
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number (proportion) of patients who definitively diagnosed as Gauchers Disease by measuring GCB activity among the patients with suspected Gauchers disease based upon clinical symptoms | — |
Countries
Japan
Contacts
Public ContactKazuko Kawakami
Mebix, Inc. Research Operation Depertment
Outcome results
None listed